[
  {
    "id": 1,
    "repeat_id": 1,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "According to the context, the following prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients:\n\n1. Number of positive nodes\n2. HER-2/neu amplification (with different levels of amplification: no amplification, > 2 copies, and > 5 copies)\n3. Log(pgr) (not explained in detail in the context)\n4. Tumor size\n5. Age\n\nThese factors were analyzed using univariate and multivariate analyses to evaluate their predictive power on disease-free survival and overall survival in node-positive patients.",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:23",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 9.638134479522705
  },
  {
    "id": 1,
    "repeat_id": 2,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "According to the context, the following specific prognostic factors were analyzed:\n\n1. Number of positive nodes\n2. HER-2/neu amplification (with different levels: no amplification, > 2 copies, and > 5 copies)\n3. Tumor size\n4. Log(pgr) \n5. Age",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:25",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.0345771312713623
  },
  {
    "id": 1,
    "repeat_id": 3,
    "question": "What prognostic factors were analyzed in relation to disease-free survival and overall survival in node-positive patients?",
    "answer": "According to the context, the following specific prognostic factors were analyzed:\n\n1. Number of positive nodes\n2. HER-2/neu amplification (with different levels: no amplification, > 2 copies, and > 5 copies)\n3. Tumor size \n4. Age",
    "ground_truth": "The excerpt indicates that the prognostic factors analyzed include the number of positive nodes and HER-2/neu status. Specifically, the paper states: 'number of positive nodes 0. 0001 0. 0002' and 'her - 2 / neu 0. 0011 < 0. 0001'. This demonstrates that both factors are statistically significant in predicting survival outcomes.",
    "source": "'number of positive nodes 0. 0001 0. 0002 her - 2 / neu 0. 0011 < 0. 0001'",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:27",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.025909423828125
  },
  {
    "id": 2,
    "repeat_id": 1,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "According to the context, the identification of the ligand in breast cancer could have \"important therapeutic implications\". This suggests that finding out what the ligand is and how it interacts with the cellular receptor could lead to new treatment options or targets for therapy.",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:29",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.7702107429504395
  },
  {
    "id": 2,
    "repeat_id": 2,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "According to the context, the identification of the ligand in breast cancer could have \"important therapeutic implications\" because it may allow for:\n\n1. Development of specific antagonists (drugs that block the action of the ligand)\n2. Identification of new targets for therapy\n3. Potential treatment options for patients with HER-2/neu positive breast cancer",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:31",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.8956670761108398
  },
  {
    "id": 2,
    "repeat_id": 3,
    "question": "What potential therapeutic implications are suggested by the identification of the ligand in breast cancer?",
    "answer": "According to the context, the identification of the ligand in breast cancer could have \"important therapeutic implications\" because it may lead to:\n\n1. Development of specific antagonists (drugs that block the action of the ligand)\n2. Identification of new targets for therapy\n3. Potential treatment options for patients with HER-2/neu positive breast cancer",
    "ground_truth": "The identification of its ligand and the development of specific antagonists could have important therapeutic implications. Specifically, the paper states: 'identification of its ligand and development of specific antagonists could have important therapeutic implications.' This demonstrates that targeting the ligand may lead to new treatment strategies for breast cancer.",
    "source": "identification of its ligand and development of specific antagonists could have important therapeutic implications.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:33",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.890911340713501
  },
  {
    "id": 3,
    "repeat_id": 1,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "According to the context, the HER-2/neu oncogene has greater prognostic value than most currently used prognostic factors, including progesterone and estrogen receptors. It is also equivalent to and independent of the best known prognosticator - number of positive lymph nodes. Additionally, the degree of HER-2/neu amplification appears to have an effect on survival, with greater copy number being associated with a worse prognosis.",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:35",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.5529592037200928
  },
  {
    "id": 3,
    "repeat_id": 2,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "According to the context, the HER-2/neu oncogene has significant prognostic value in human breast cancer, indicating that it may be a useful marker for predicting patient outcomes and guiding treatment decisions. Specifically, it is:\n\n1. A better predictor of prognosis than other factors\n2. Equivalent to (and independent of) the number of positive lymph nodes\n3. Associated with worse survival outcomes when overexpressed or amplified",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:38",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.430727958679199
  },
  {
    "id": 3,
    "repeat_id": 3,
    "question": "What is the significance of the her-2/neu oncogene in human breast cancer as discussed in the excerpt?",
    "answer": "According to the context, the HER-2/neu oncogene has greater prognostic value than most currently used prognostic factors. It also appears to have an effect on survival, with greater copy number being associated with a worse prognosis. This suggests that the HER-2/neu gene may play a significant role in the development and progression of breast cancer.",
    "ground_truth": "The her-2/neu oncogene is significant in human breast cancer as it has been shown to be amplified in breast cancer cell lines. Specifically, the paper states: 'this gene has been shown to be amplified in human breast cancer cell lines.' This demonstrates that amplification of this oncogene may correlate with disease progression.",
    "source": "'this gene has been shown to be amplified in human breast cancer cell lines.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:40",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.2396137714385986
  },
  {
    "id": 4,
    "repeat_id": 1,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "According to the context, southern blot analysis was not mentioned, but rather Southern blot is implied as \"Southern blot analysis\" is a technique that was likely used, however it's actually mentioned that \"the image displays southern blot analysis of 79 of the 189 breast tumors used in this study.\"",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:42",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.111543655395508
  },
  {
    "id": 4,
    "repeat_id": 2,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "According to the context, Southern blot analysis was used to analyze alterations in the HER-2/neu gene. Specifically, it is mentioned that \"the image displays southern blot analysis of 79 of the 189 breast tumors used in this study.\"",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:44",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.983299732208252
  },
  {
    "id": 4,
    "repeat_id": 3,
    "question": "What method was used to analyze alterations in the her - 2 / neu gene in the study?",
    "answer": "According to the context, Southern blot analysis was used.",
    "ground_truth": "The study utilized Southern blot analysis to evaluate alterations in the her - 2 / neu gene. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.' This demonstrates that the researchers employed a molecular technique to detect specific genetic alterations.",
    "source": "'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32 p - labeled her - 2 / neu - 1 probe.'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:46",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.6239385604858398
  },
  {
    "id": 5,
    "repeat_id": 1,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "According to the context, a 32P-labeled HER-2/neu-1 probe was used for Southern blot analysis with EcoRI-digested DNA from individual tumors.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:48",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.8288235664367676
  },
  {
    "id": 5,
    "repeat_id": 2,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "According to the context, a 32P-labeled HER-2/neu-1 probe was used for Southern blot analysis with EcoRI-digested DNA from individual tumors.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:49",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.8549599647521973
  },
  {
    "id": 5,
    "repeat_id": 3,
    "question": "What specific technique and probe were used to evaluate alterations in the HER-2/neu gene in breast cancer tumors?",
    "answer": "According to the context, \"DNA from individual tumors was prepared as described, digested with EcoRI, and then analyzed using a 32P-labeled HER-2/neu-1 probe\" for Southern blot analysis.",
    "ground_truth": "According to the excerpt, Southern blot analysis with a 32P-labeled HER-2/neu-1 probe was used to evaluate alterations in the HER-2/neu gene in breast cancer tumors. Specifically, the paper states: 'dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.' This demonstrates that the researchers used a specific molecular biology technique (Southern blot) with a radioactively labeled probe to detect gene amplification in tumor DNA samples.",
    "source": "dna from individual tumors was prepared as described, digested with eco ri, and subjected to southern blot analysis with a 32p - labeled her - 2 / neu - 1 probe, which is known to detect a 13 - kb hybridizing band in human dna.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:51:51",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.9617946147918701
  },
  {
    "id": 6,
    "repeat_id": 1,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "According to the context, it is mentioned that \"the image displays southern blot analysis of 79 of the 189 breast tumors used in this study\". However, no specific observations are made about the HER-2/neu loci in the study.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:53",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.9876902103424072
  },
  {
    "id": 6,
    "repeat_id": 2,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "According to the context, Figure 1 shows the analysis of alterations of the HER-2/neu gene in human breast cancer, but no specific details are provided about what was observed regarding the HER-2/neu loci.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:55",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.9712820053100586
  },
  {
    "id": 6,
    "repeat_id": 3,
    "question": "What was observed regarding the HER-2/neu loci in the study?",
    "answer": "Unfortunately, the context does not provide any information on what was specifically observed regarding the HER-2/neu loci in the study. It only mentions that Figure 1 shows the analysis of alterations of the HER-2/neu gene in human breast cancer, but it doesn't elaborate further.",
    "ground_truth": "The study observed that in two of the three cases, the rearrangement of the HER-2/neu loci was identical, and additionally, two of the rearranged HER-2/neu loci were amplified. Specifically, the excerpt states: 'also, two of the rearranged her - 2 / neu loci were amplified.' This indicates a potential significance of these rearrangements in the context of breast cancer.",
    "source": "'also, two of the rearranged her - 2 / neu loci were amplified.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:51:57",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.107156753540039
  },
  {
    "id": 7,
    "repeat_id": 1,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "According to the context, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR (Epidermal Growth Factor Receptor) gene. Specifically, it states that \"comparisons of the predicted amino acid sequences show that the HER-2/neu protein has a greater number of potential phosphorylation sites and is larger than the EGFR protein\".",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:00",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.26578688621521
  },
  {
    "id": 7,
    "repeat_id": 2,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "According to the context, the protein encoded by the HER-2/neu gene is approximately 1677 amino acids long, while the protein encoded by the EGFR gene is approximately 1048 amino acids long. This means that the HER-2/neu protein is larger than the EGFR protein.",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:02",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.1139492988586426
  },
  {
    "id": 7,
    "repeat_id": 3,
    "question": "How do the proteins produced by the HER-2/neu and EGFR genes differ in size?",
    "answer": "According to the context, the protein encoded by the HER-2/neu gene is approximately 1677 amino acids long, while the protein encoded by the EGFR (Epidermal Growth Factor Receptor) gene is approximately 1048 amino acids long. This means that the HER-2/neu protein is larger than the EGFR protein.",
    "ground_truth": "According to the excerpt, the protein encoded by the HER-2/neu gene is larger than the protein encoded by the EGFR gene. Specifically, the paper states that the HER-2/neu protein is \"185,000 daltons, as compared to the 170,000-dalton protein encoded by the egfr gene.\"",
    "source": "finally, the protein encoded by the her - 2 / neu gene is 185, 000 daltons, as compared to the 170, 000 - dalton protein encoded by the egfr gene.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:04",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.22798752784729
  },
  {
    "id": 8,
    "repeat_id": 1,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "According to the context, amplification of the HER-2/neu gene has a significant predictor effect on both overall survival and relapse in node-positive breast cancer patients. Specifically, it states that \"amplification of the HER-2/neu gene is associated with poorer prognosis in node-positive breast cancer\".",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:06",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.251159906387329
  },
  {
    "id": 8,
    "repeat_id": 2,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "According to the context, amplification of the HER-2/neu gene has a significant predictor effect on both overall survival and relapse in node-positive breast cancer patients. Specifically, it states that \"the degree of HER-2/neu amplification appears to have an effect on survival, with greater copy number being associated with a worse prognosis\".",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:09",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.331995725631714
  },
  {
    "id": 8,
    "repeat_id": 3,
    "question": "What impact does HER-2/neu amplification have on overall survival and relapse in node-positive breast cancer patients according to the excerpt?",
    "answer": "According to the context, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. It retains its prognostic significance even when adjustments are made for other factors.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu amplification have significantly different outcomes compared to those without amplification. Specifically, it states: 'the curves dramatically show that patients with her - 2 / neu'. This suggests that higher levels of HER-2/neu amplification correlate with poorer overall survival and increased relapse rates in node-positive patients.",
    "source": "'the curves dramatically show that patients with her - 2 / neu'",
    "difficulty": "easy",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:11",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.1150152683258057
  },
  {
    "id": 9,
    "repeat_id": 1,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "According to the context, patients with greater than 5 copies of the HER-2/neu gene have poorer outcomes, including a worse prognosis for overall survival and an increased risk of relapse. Additionally, it states that these patients show evidence of rearrangements in the HER-2/neu gene, which is associated with a higher degree of amplification.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:13",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.2458395957946777
  },
  {
    "id": 9,
    "repeat_id": 2,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "According to the context, HER-2/neu gene amplification is associated with significantly worse outcomes in terms of both disease-free survival and overall survival. Specifically, patients with greater than 5 copies of the gene have even shorter disease-free survival times (p = 0.69) and overall survival times (not specified).",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:15",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.1779441833496094
  },
  {
    "id": 9,
    "repeat_id": 3,
    "question": "What impact does HER-2/neu gene amplification have on patient outcomes according to the excerpt?",
    "answer": "According to the context, patients with HER-2/neu gene amplification, particularly those with >5 copies, have significantly worse outcomes in terms of both disease-free survival and overall survival. Additionally, they tend to relapse faster and have shorter overall survival times compared to those without amplification.",
    "ground_truth": "The excerpt indicates that patients with HER-2/neu gene amplification, particularly those with more than 5 copies, had significantly worse outcomes. Specifically, it states: 'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'. This demonstrates that higher levels of gene amplification correlate with poorer survival rates.",
    "source": "'patients with greater than five copies of her - 2 / neu had even shorter disease - free survival times (p = 0. 015) and overall survival times (p = 0. 06)'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:17",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.100121259689331
  },
  {
    "id": 10,
    "repeat_id": 1,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "According to the context, the evidence supporting the link between proto-oncogenes and human malignancies includes:\n\n1. Sequence homology between human proto-oncogenes and oncogenic proteins in other organisms.\n2. Amplification of proto-oncogenes in certain cancers.\n3. Association of proto-oncogene amplification with tumor progression in specific cancers.\n\nThese types of evidence suggest that the overexpression or amplification of proto-oncogenes can contribute to the development and progression of human malignancies.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:20",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.5256359577178955
  },
  {
    "id": 10,
    "repeat_id": 2,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "According to the context, the evidence supporting the link between proto-oncogenes and human malignancies includes:\n\n1. Amplification of specific proto-oncogenes in certain cancers.\n2. Localization of proto-oncogenes at or near the site of specific chromosomal translocations associated with cancer.\n3. Increased expression of specific proto-oncogenes in some human malignancies.\n\nThese types of evidence suggest that the overexpression or aberrant regulation of proto-oncogenes can contribute to the development and progression of human malignancies.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:22",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.6663761138916016
  },
  {
    "id": 10,
    "repeat_id": 3,
    "question": "What types of evidence support the link between proto-oncogenes and human malignancies according to the excerpt?",
    "answer": "According to the context, the evidence supporting the link between proto-oncogenes and human malignancies includes:\n\n1. Sequence homology with viral oncogenes in transforming retroviruses.\n2. Transfection studies showing the oncogenic potential of specific proto-oncogenes.\n3. Amplification of proto-oncogenes in certain cancers.\n4. Localization of proto-oncogenes at or near the site of chromosomal translocations associated with cancer.\n\nThese types of evidence suggest that the overexpression or aberrant regulation of proto-oncogenes can contribute to the development and progression of human malignancies.",
    "ground_truth": "The excerpt outlines several types of evidence that support the link between proto-oncogenes and human malignancies. It states that this evidence is derived from 'studies of animal models, tumor cell lines, and actual human tumors.' Additionally, it mentions specific data including 'sequence homology between human proto-oncogenes and the viral oncogenes of transforming retroviruses,' 'transfection studies showing the transforming potential of proto-oncogenes in nih 3 t 3 cells and primary embryo fibroblasts,' and 'the central role of certain proto-oncogenes in tumorigen.' This demonstrates that the relationship is supported by both experimental and comparative studies.",
    "source": "'the evidence linking proto - oncogenes to the induction or maintenance of human malignancies is largely circumstantial, but has become increasingly compelling. this circumstantial evidence is derived from studies of animal models, tumor cell lines, and actual human tumors.'",
    "difficulty": "medium",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:25",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.8217031955718994
  },
  {
    "id": 11,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of poorer outcomes in breast cancer patients. Specifically, it retains its prognostic significance even when adjustments are made for other known prognostic factors.\n\nIn comparison to other factors, the excerpt states that amplification of the HER-2/neu gene has a more significant impact on prognosis than some other established prognostic factors.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:28",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.4313971996307373
  },
  {
    "id": 11,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. It retains its prognostic significance even when adjustments are made for other known prognostic factors.\n\nIn comparison, amplification of HER-2/neu has greater prognostic value than some currently used prognosticators, including progesterone and estrogen receptors, and is equivalent to the number of positive lymph nodes.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:30",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.5977818965911865
  },
  {
    "id": 11,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification impact prognosis in breast cancer patients, and how does its prognostic value compare to other factors?",
    "answer": "According to the excerpt, HER-2/neu gene amplification appears to have a worse prognosis for patients with greater copy numbers. Specifically:\n\n* Patients with >5 copies of the HER-2/neu gene tend to relapse faster and have shorter overall survival times.\n* Amplification of HER-2/neu has greater prognostic value than some currently used prognosticators, including progesterone and estrogen receptors.\n\nNote that the excerpt does not provide a direct comparison between HER-2/neu amplification and other factors in terms of absolute prognosis.",
    "ground_truth": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of both overall survival and time to relapse in breast cancer patients. The study found that it retained its significance even when adjusted for other known prognostic factors. Notably, HER-2/neu amplification showed greater prognostic value than most currently used factors, including hormonal-receptor status, particularly in lymph node-positive disease. This suggests that the HER-2/neu gene may play a crucial role in the biological behavior and/or pathogenesis of human breast cancer.",
    "source": "amplification of the her - 2 / neu gene was a significant predictor of both overall survival and time to relapse in patients with breast cancer. it retained its significance even when adjustments were made for other known prognostic factors. moreover, her - 2 / neu amplification had greater prognostic value than most currently used prognostic factors, including hormonal - receptor status, in lymph node - positive disease. these data indicate that this gene may play a role in the biologic behavior and / or pathogenesis of human breast cancer.",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:33",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.7410337924957275
  },
  {
    "id": 12,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. Specifically, it retains its prognostic significance even when adjustments are made for other known prognostic factors.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:35",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.1556313037872314
  },
  {
    "id": 12,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, HER-2/neu gene amplification is a significant predictor of poorer outcomes in node-positive breast cancer patients. It appears that 15% of breast cancer patients with stage I disease (node-negative) have HER-2/neu amplification, and this may be an additional group where HER-2/neu measurements can impact predicting tumor behavior and treatment strategy.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:38",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.355271577835083
  },
  {
    "id": 12,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. It retains its prognostic significance even when adjustments are made for other known prognostic factors. This suggests that HER-2/neu gene amplification can provide additional information about prognosis beyond what is available from other established prognostic factors.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor for patients with node-positive breast cancer. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant in predicting disease behavior, even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients, even when other prognostic factors were taken into account'",
    "difficulty": "easy",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:40",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.4302682876586914
  },
  {
    "id": 13,
    "repeat_id": 1,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "The excerpt does not specifically state the statistical significance of HER-2/neu as a prognostic factor. However, it mentions that amplification of the HER-2/neu gene \"retains its prognostic significance even when adjustments are made for other known prognostic factors\". This implies that HER-2/neu remains an important predictor of relapse in node-positive breast cancer patients, but the exact statistical significance is not provided.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:43",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.614596366882324
  },
  {
    "id": 13,
    "repeat_id": 2,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The exact statistical significance is not provided in the excerpt.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:45",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.981180191040039
  },
  {
    "id": 13,
    "repeat_id": 3,
    "question": "What is the statistical significance of HER-2/neu as a prognostic factor for relapse in node-positive breast cancer patients according to the multivariate analysis?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The exact statistical significance is not provided in the excerpt. However, it does mention that amplification of HER-2/neu had \"greater prognostic value than most currently used prognostic factors\", implying a significant association with relapse in node-positive breast cancer patients.",
    "ground_truth": "According to the multivariate analysis presented in the excerpt, HER-2/neu is a statistically significant prognostic factor for relapse in node-positive breast cancer patients. Specifically, the paper states that HER-2/neu has a p-value of '0.001 (0.1378 \u00b1 0.0425)' for relapse in the multivariate analysis. This demonstrates that HER-2/neu is a strong predictor of disease recurrence, with a highly significant p-value of 0.001.",
    "source": "her - 2 / neu 0. 0011 < 0. 0001 0. 02 ( 0. 0872 \u00b1 0. 0388 ) 0. 001 ( 0. 1378 \u00b1 0. 0425 )",
    "difficulty": "hard",
    "confidence": "medium",
    "timestamp": "2025-05-14 13:52:47",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.414777994155884
  },
  {
    "id": 14,
    "repeat_id": 1,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. According to the excerpt, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. It retains its prognostic significance even when adjustments are made for other known prognostic factors.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:49",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.340226173400879
  },
  {
    "id": 14,
    "repeat_id": 2,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, HER-2/neu gene amplification has a significant and independent prognostic value in node-positive breast cancer patients, even when other known prognostic factors are considered. This suggests that HER-2/neu amplification provides additional information about prognosis beyond what is available from other established prognostic factors.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:52",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.2792320251464844
  },
  {
    "id": 14,
    "repeat_id": 3,
    "question": "How does HER-2/neu gene amplification relate to patient prognosis in node-positive breast cancer cases?",
    "answer": "According to the excerpt, amplification of the HER-2/neu gene is a significant predictor of both overall survival and time to relapse in node-positive patients with breast cancer. It retains its prognostic significance even when adjustments are made for other known prognostic factors. This implies that HER-2/neu amplification can provide valuable information about prognosis, potentially guiding treatment decisions.",
    "ground_truth": "The excerpt indicates that amplification of the HER-2/neu gene is a strong prognostic factor in node-positive breast cancer patients. Specifically, it states: 'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients.' This demonstrates that HER-2/neu amplification is significant even when considering other prognostic factors.",
    "source": "'amplification of the gene continued to be a strong prognostic factor, providing additional and independent predictive information on both time to relapse and overall survival in these patients'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:54",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.3775992393493652
  },
  {
    "id": 15,
    "repeat_id": 1,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The excerpt draws no explicit conclusions about the generality of gene amplification in human breast cancer beyond its significance for HER-2/neu and another related tyrosine kinase receptor in node-positive patients. However, it does suggest that amplification of this particular gene may play a role in the biologic behavior and pathogenesis of breast cancer.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:56",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.3353824615478516
  },
  {
    "id": 15,
    "repeat_id": 2,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "The excerpt suggests that HER-2/neu amplification is a significant predictor of prognosis in node-positive breast cancer patients, implying that gene amplification may be a more general phenomenon in this type of cancer, beyond just this specific receptor. However, the excerpt does not provide conclusive evidence for the generality of gene amplification across all types of human breast cancer.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:52:59",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.3163235187530518
  },
  {
    "id": 15,
    "repeat_id": 3,
    "question": "Based on the comparison of amplification levels for two related tyrosine kinase receptors in human breast cancer, what conclusion does the excerpt draw regarding the generality of gene amplification as a phenomenon in this specific malignancy?",
    "answer": "According to the excerpt, the phenomenon of gene amplification is not general across all related tyrosine kinase receptors in human breast cancer. The comparison between HER-2/neu and another related receptor suggests that amplification of one does not necessarily imply amplification of the other, indicating that gene amplification may be a more specific event in this particular malignancy rather than a universal characteristic.",
    "ground_truth": "The excerpt concludes that the significant difference in amplification levels between the two related tyrosine kinase receptors suggests that gene amplification is not a universally applicable phenomenon for this class of receptors in human breast cancer. Specifically, the paper states: \"of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.\"",
    "source": "of the former to be 14 times greater than that of the latter, indicating that the phenomenon of gene amplification is not a general one for a related tyrosine kinase - specific receptor in human breast cancer.",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:01",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.409226417541504
  },
  {
    "id": 16,
    "repeat_id": 1,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "According to the excerpt, Cox's partial nonparametric regression analysis was used to evaluate the predictive power of prognostic factors in the study.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:03",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.861933708190918
  },
  {
    "id": 16,
    "repeat_id": 2,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model was specifically mentioned as being used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:05",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.7507221698760986
  },
  {
    "id": 16,
    "repeat_id": 3,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model, also known as Cox proportional hazards regression or Cox regression, was used to evaluate the predictive power of prognostic factors in the study.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "medium",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:07",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.8205180168151855
  },
  {
    "id": 17,
    "repeat_id": 1,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The excerpt does not provide a structural description of the protein [Chunk 8]. However, it mentions that amplification of the HER-2/neu gene leads to overproduction of its protein product, which is likely a tyrosine kinase receptor. This implies that the protein is likely a cellular receptor due to its association with the HER-2/neu gene and its potential role in signaling pathways.",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:09",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.548995018005371
  },
  {
    "id": 17,
    "repeat_id": 2,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The excerpt does not provide a structural description of the protein [Chunk 8]. However, based on the general information provided in the excerpt about HER-2/neu and its relationship with tyrosine kinase receptors, it can be inferred that a similar protein is likely a cellular receptor due to its potential role in signaling pathways.",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:11",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.225955009460449
  },
  {
    "id": 17,
    "repeat_id": 3,
    "question": "Based on the structural description provided in the excerpt for the protein identified as \"[Chunk 8]\", what specific features lead to the inference that it is likely a cellular receptor?",
    "answer": "Sorry, I am allowed to answer questions related to the context only. The excerpt does not provide a structural description of the protein [Chunk 8]. However, according to the provided information about other proteins like c-erbb (EGFR), which encodes the EGF receptor and is highly homologous to the transforming gene of the avian sarcoma virus, it can be inferred that similar proteins are likely cellular receptors due to their similarity in structure and function.",
    "ground_truth": "According to the excerpt, the inference that the protein \"[Chunk 8]\" is likely a cellular receptor is based on its specific domain structure. The text states: \"[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.\" These distinct domains, particularly the extracellular and transmembrane components, are characteristic of receptor proteins.",
    "source": "[Chunk 8] has an extracellular domain, a transmembrane domain that includes two cysteine - rich repeat clusters, and an intracellular kinase domain, indicating that it too is likely to be a cellular receptor for an as yet unidentified ligand.",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:14",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 2.421644449234009
  },
  {
    "id": 18,
    "repeat_id": 1,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model was used to evaluate the predictive power of prognostic factors in the study.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:15",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.7140469551086426
  },
  {
    "id": 18,
    "repeat_id": 2,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "The Cox's partial nonparametric regression analysis was specifically mentioned as being used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:17",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.949091911315918
  },
  {
    "id": 18,
    "repeat_id": 3,
    "question": "What statistical method was used to evaluate the predictive power of prognostic factors in the study?",
    "answer": "Cox's partial nonparametric regression model, also known as Cox proportional hazards regression or Cox regression, was used to evaluate the predictive power of prognostic factors in the study.",
    "ground_truth": "The study utilized Cox's partial nonparametric regression model to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner. Specifically, the paper states: 'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.' This demonstrates that the researchers aimed to analyze multiple factors simultaneously to understand their impact on patient outcomes.",
    "source": "'cox 's partial nonparametric regression model was used to evaluate the predictive power of various combinations and interactions of prognostic factors in a multivariate manner.'",
    "difficulty": "hard",
    "confidence": "high",
    "timestamp": "2025-05-14 13:53:19",
    "model_name": "llama3.2:3b",
    "model_provider": "ollama",
    "temperature": 0.3,
    "response_time": 1.9094867706298828
  }
]